Back to search

Japan· JP-2452003F1035

フルドロコルチゾン酢酸エステル

A medicinal product containing フルドロコルチゾン酢酸エステル, registered in Japan by サンドファーマ, on the national reimbursement list.

On Japan’s NHI price list

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedフルドロコルチゾン酢酸エステルATC—REGISTER NO.JP-2452003F1035PACKS LISTED0CHECKEDSeptember 25, 2026

The record

At a glance

MHLW / PMDA (Japan)
Active substance
フルドロコルチゾン酢酸エステル
Manufacturer
サンドファーマ
Country
Japan (JP)
ATC code
—
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

フルドロコルチゾン酢酸エステル in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All フルドロコルチゾン酢酸エステル products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Astonin H
  • Bulgaria · Кортинеф
  • Germany · Astonin H, Fludrocortison Accord
  • Denmark · Cortiflix, Florinef
  • Spain · Astonín, Fludrocortisona
  • Finland · Cortiflix, Florinef
  • France · Flucortac, Fludrocortisone Acetate Accord
  • United Kingdom (Northern Ireland) · Fludrocortisone Acetate, Fludrocortisone Acetate Accord-Uk
  • Greece · Felusil
  • Croatia · Zonta
  • Hungary · Astonin
  • Ireland · Fludrocortisone Acetate Mylan, Fludrocortisone Acetate Renata
  • Iceland · Florinef
  • Lithuania · Cortineff
  • Luxembourg · Astonin H
  • Latvia · Cortineff, Fludrocortisone Acetate Renata
  • Malta · Fludrocortisone Acetate Renata
  • Netherlands · Florinef Acetaat, Fludrace
  • Norway · Cortiflix, Florinef
  • Poland · Cortineff, Cortineff Ophtalm
  • Portugal · Fludrocortisona Renata
  • Romania · Astonin H
  • Sweden · Cortiflix, Florinef
  • Slovenia · Zonta
  • Slovakia · Zonta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0039539-289b-4db4-8474-f369f7534f88
GET /v1/drugs/e0039539-289b-4db4-8474-f369f7534f88?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.1mg1錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2452003F1035",
  "category": "内用薬",
  "price_yen": 188.7,
  "generic_name": "フルドロコルチゾン酢酸エステル",
  "product_name_jp": null,
  "therapeutic_class": "2452",
  "transitional_expiry": null
}

See everything about フルドロコルチゾン酢酸エステル.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.